Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $71.1 million.

  • Sanara MedTech's Liabilities and Shareholders Equity fell 1971.51% to $71.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.3 million, marking a year-over-year increase of 1552.42%. This contributed to the annual value of $88.1 million for FY2024, which is 1925.09% up from last year.
  • Latest data reveals that Sanara MedTech reported Liabilities and Shareholders Equity of $71.1 million as of Q3 2025, which was down 1971.51% from $98.8 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Liabilities and Shareholders Equity registered a high of $98.8 million during Q2 2025, and its lowest value of $33.9 million during Q1 2022.
  • Over the past 5 years, Sanara MedTech's median Liabilities and Shareholders Equity value was $70.9 million (recorded in 2024), while the average stood at $64.4 million.
  • In the last 5 years, Sanara MedTech's Liabilities and Shareholders Equity surged by 30964.21% in 2021 and then crashed by 1971.51% in 2025.
  • Sanara MedTech's Liabilities and Shareholders Equity (Quarter) stood at $36.4 million in 2021, then soared by 67.7% to $61.0 million in 2022, then rose by 21.03% to $73.9 million in 2023, then increased by 19.25% to $88.1 million in 2024, then fell by 19.3% to $71.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $71.1 million in Q3 2025, compared to $98.8 million in Q2 2025 and $96.4 million in Q1 2025.